# LIQUIDIA CORPORATION (LQDA) · Edgar & Edgarette company card

> Liquidia (LQDA) grew revenue 1031% in FY2025 to $158 million, operating margin -32.5% against a -3.8% median for pharmaceutical preparations, equity 13.6% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1819576 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/LQDA) · [JSON](https://www.pops4.com/boards/company/LQDA.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $158M |
| Revenue growth, 1 year | 1031.2% |
| Revenue growth per year | 87.3% |
| Operating margin | -32.5% (prior year -866.6%) |
| Net margin | -43.5% |
| Operating cash flow | −$36M |
| Capital spending | $4M |
| Free cash flow | −$40M |
| Cash | $191M |
| Long-term debt | — |
| Total assets | $328M |
| Total equity | $45M |
| Equity ÷ assets | 13.6% |
| Return on equity | -154.0% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -4.36 (distress zone)
- Piotroski F: 4 of 9 (middling)
- Health Harbor boat: Old boat · three warning signs · operating cash flow was negative; operating loss: a margin of -32.5% in FY2025; revenue is hard to predict: its 80% range is ±26%
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $158.3M (FY2025). Experience: revenue up 1031.2% on the year, up 87.3% a year over 4 years; operating margin -32.5%, up from -866.6%. Soundness: equity 13.6% of assets, return on equity -154.0%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $801.1M and $1.4B next year (method v4.1: its own 3-year record of growth weighed at 40% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $699.6M to $1.6B. A statistical range, not company guidance. Against peers (114 filers, $50M+ revenue, pharmaceutical preparations): operating margin -32.5% against a -3.8% median; growth 1031.2% against 13.7%.

Range logged 2026-10-15, receipt 94c0fda247bdd111, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 1, latest 2026-11-18 ([filing](https://www.sec.gov/Archives/edgar/data/1819576/000110465926129745/0001104659-26-129745-index.htm))

## Recent filings

- 8-K · filed 2026-11-18 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1819576/000110465926129745/0001104659-26-129745-index.htm)
- 8-K · filed 2026-11-10 · 2.02 Results of Operations and Financial Condition; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1819576/000110465926124770/0001104659-26-124770-index.htm)
- 10-Q · filed 2026-11-10 · [filing](https://www.sec.gov/Archives/edgar/data/1819576/000110465926124752/0001104659-26-124752-index.htm)
- 8-K · filed 2026-10-14 · 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1819576/000110465926115672/0001104659-26-115672-index.htm)
- 8-K · filed 2026-09-30 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1819576/000110465926112420/0001104659-26-112420-index.htm)
- 8-K · filed 2026-09-03 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1819576/000110465926104929/0001104659-26-104929-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001819576.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1819576

## Cite

POPS4, Edgar & Edgarette: LIQUIDIA CORPORATION (LQDA) company card, from the company's own SEC filings, accessed 2026-11-19, https://www.pops4.com/boards/company/LQDA. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

